BioCentury
ARTICLE | Clinical News

Cantrixil regulatory update

May 4, 2015 7:00 AM UTC

FDA granted Orphan Drug designation to Novogen’s Cantrixil to treat ovarian cancer. Cantrixil is a cyclodextrin envelope containing cytotoxic TRXE-002, a dimer of 2 benzopyran rings called a super-be...